{
    "applicationNumber": "BR 11 2021 021626-0",
    "filingDate": "30/04/2020",
    "grantDate": null,
    "title": "PROTE\u00cdNA SELECIONADA A PARTIR DO GRUPO QUE CONSISTE EM CHRDLL, FAM3C, FAM3B E FRAGMENTOS DA MESMA OU UM POLINUCLEOT\u00cdDEO QUE CODIFICA A MESMA, PROTE\u00cdNA OU POLINUCLEOT\u00cdDEO PARA USO, VETOR PARA USO NO TRATAMENTO OU REDU\u00c7\u00c3O DO RISCO DE DOEN\u00c7A CARD\u00cdACA, E, COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA",
    "nationalPhaseDate": [
        "28/10/2021"
    ],
    "internationalApplication": {
        "pctNumber": "PCT EP2020/062156",
        "pctDate": "30/04/2020",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "GB",
            "priorityNumber": "1906052.4",
            "priorityDate": "30/04/2019"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2653"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2659"
        }
    ],
    "inventors": [
        "MAURO GIACCA",
        "GIULIA RUOZI",
        "FRANCESCA BORTOLOTTI"
    ],
    "holders": [
        301596
    ],
    "ipcCodes": [
        "A61K 48/00",
        "A61P 9/00",
        "C07K 14/47",
        "A61P 9/10",
        "A61K 38/17",
        "C07K 14/52"
    ]
}